scispace - formally typeset
L

Lucia Mangone

Researcher at Academy for Urban School Leadership

Publications -  129
Citations -  7341

Lucia Mangone is an academic researcher from Academy for Urban School Leadership. The author has contributed to research in topics: Cancer & Population. The author has an hindex of 27, co-authored 105 publications receiving 5221 citations. Previous affiliations of Lucia Mangone include Santa Maria Nuova Hospital.

Papers
More filters
Journal ArticleDOI

Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries.

Claudia Allemani, +594 more
- 17 Mar 2018 - 
TL;DR: For most cancers, 5-year net survival remains among the highest in the world in the USA and Canada, in Australia and New Zealand, and in Finland, Iceland, Norway, and Sweden, while for many cancers, Denmark is closing the survival gap with the other Nordic countries.
Journal ArticleDOI

International incidence of childhood cancer, 2001-10 a population-based registry study

Eva Steliarova-Foucher, +229 more
- 01 Jun 2017 - 
TL;DR: This unique global source of childhood cancer incidence will be used for aetiological research and to inform public health policy, potentially contributing towards attaining several targets of the Sustainable Development Goals.
Journal ArticleDOI

Recent cancer survival in Europe: a 2000-02 period analysis of EUROCARE-4 data.

TL;DR: Age-adjusted 5-year period survival improved for patients diagnosed in 2000-02, especially for patients with colorectal, breast, prostate, and thyroid cancer, Hodgkin's disease, and non-Hodgkin lymphoma, although, patients in eastern European had the highest improvement in survival for major cancer sites during 1991-2002.
Journal ArticleDOI

Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet—a population-based study

Gemma Gatta, +134 more
- 01 Aug 2017 - 
TL;DR: The estimates of the burden of rare cancers in Europe, their time trends in incidence and survival, and information about centralisation of treatments in seven European countries are updated to help improve case management and survival.
Journal ArticleDOI

Progress in colorectal cancer survival in Europe from the late 1980s to the early 21st century: The EUROCARE study

TL;DR: There is a huge potential for reducing the burden of CRC in Europe by more widespread and equal delivery of existing options of effective early detection and curative treatment to the European population.